866-997-4948(US-Canada Toll Free)

United States Anti-Obesity Drugs Market Report 2017

Published By :

QYResearch

Published Date : Jan 2017

Category :

Pharmaceutical

No. of Pages : 124 Pages

Notes:
Sales, means the sales volume of Anti-Obesity Drugs
Revenue, means the sales value of Anti-Obesity Drugs

This report studies sales (consumption) of Anti-Obesity Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Merck
F.Hoffmann-La Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Prescription Drugs
OTC Drugs
Split by applications, this report focuses on sales, market share and growth rate of Anti-Obesity Drugs in each application, can be divided into
6-18 Callant
18-30 Adult
30-60Middle-Aged
Others

Table of Contents

United States Anti-Obesity Drugs Market Report 2017
1 Anti-Obesity Drugs Overview
1.1 Product Overview and Scope of Anti-Obesity Drugs
1.2 Classification of Anti-Obesity Drugs
1.2.1 Prescription Drugs
1.2.2 OTC Drugs
1.3 Application of Anti-Obesity Drugs
1.3.1 6-18 Callant
1.3.2 18-30 Adult
1.3.3 30-60Middle-Aged
1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Anti-Obesity Drugs (2012-2022)
1.4.1 United States Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
1.4.2 United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)

2 United States Anti-Obesity Drugs Competition by Manufacturers
2.1 United States Anti-Obesity Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Anti-Obesity Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Anti-Obesity Drugs Average Price by Manufactures (2015 and 2016)
2.4 Anti-Obesity Drugs Market Competitive Situation and Trends
2.4.1 Anti-Obesity Drugs Market Concentration Rate
2.4.2 Anti-Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Anti-Obesity Drugs Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Anti-Obesity Drugs Sales and Market Share by States (2012-2017)
3.2 United States Anti-Obesity Drugs Revenue and Market Share by States (2012-2017)
3.3 United States Anti-Obesity Drugs Price by States (2012-2017)

4 United States Anti-Obesity Drugs Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Anti-Obesity Drugs Sales and Market Share by Type (2012-2017)
4.2 United States Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Anti-Obesity Drugs Price by Type (2012-2017)
4.4 United States Anti-Obesity Drugs Sales Growth Rate by Type (2012-2017)

5 United States Anti-Obesity Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Anti-Obesity Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Anti-Obesity Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Anti-Obesity Drugs Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Anti-Obesity Drugs Product Type, Application and Specification
6.1.2.1 Prescription Drugs
6.1.2.2 OTC Drugs
6.1.3 Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Merck
6.2.2 Anti-Obesity Drugs Product Type, Application and Specification
6.2.2.1 Prescription Drugs
6.2.2.2 OTC Drugs
6.2.3 Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 F.Hoffmann-La Roche
6.3.2 Anti-Obesity Drugs Product Type, Application and Specification
6.3.2.1 Prescription Drugs
6.3.2.2 OTC Drugs
6.3.3 F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
6.4.2 Anti-Obesity Drugs Product Type, Application and Specification
6.4.2.1 Prescription Drugs
6.4.2.2 OTC Drugs
6.4.3 GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 AstraZeneca
6.5.2 Anti-Obesity Drugs Product Type, Application and Specification
6.5.2.1 Prescription Drugs
6.5.2.2 OTC Drugs
6.5.3 AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
6.6.2 Anti-Obesity Drugs Product Type, Application and Specification
6.6.2.1 Prescription Drugs
6.6.2.2 OTC Drugs
6.6.3 Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.2 Anti-Obesity Drugs Product Type, Application and Specification
6.7.2.1 Prescription Drugs
6.7.2.2 OTC Drugs
6.7.3 Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Eisai
6.8.2 Anti-Obesity Drugs Product Type, Application and Specification
6.8.2.1 Prescription Drugs
6.8.2.2 OTC Drugs
6.8.3 Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Norgine
6.9.2 Anti-Obesity Drugs Product Type, Application and Specification
6.9.2.1 Prescription Drugs
6.9.2.2 OTC Drugs
6.9.3 Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Arena Pharmaceuticals
6.10.2 Anti-Obesity Drugs Product Type, Application and Specification
6.10.2.1 Prescription Drugs
6.10.2.2 OTC Drugs
6.10.3 Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Orexigen Therapeutics
6.12 Vivus
6.13 Alizyme
6.14 Rhythm Pharmaceuticals
6.15 Shionogi
6.16 Zafgan

7 Anti-Obesity Drugs Manufacturing Cost Analysis
7.1 Anti-Obesity Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti-Obesity Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Anti-Obesity Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Anti-Obesity Drugs Market Forecast (2017-2022)
11.1 United States Anti-Obesity Drugs Sales, Revenue Forecast (2017-2022)
11.2 United States Anti-Obesity Drugs Sales Forecast by Type (2017-2022)
11.3 United States Anti-Obesity Drugs Sales Forecast by Application (2017-2022)
11.4 Anti-Obesity Drugs Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Anti-Obesity Drugs
Table Classification of Anti-Obesity Drugs
Figure United States Sales Market Share of Anti-Obesity Drugs by Type in 2015
Figure Prescription Drugs Picture
Figure OTC Drugs Picture
Table Application of Anti-Obesity Drugs
Figure United States Sales Market Share of Anti-Obesity Drugs by Application in 2015
Figure 6-18 Callant Examples
Figure 18-30 Adult Examples
Figure 30-60Middle-Aged Examples
Figure Others Examples
Figure United States Anti-Obesity Drugs Sales and Growth Rate (2012-2022)
Figure United States Anti-Obesity Drugs Revenue and Growth Rate (2012-2022)
Table United States Anti-Obesity Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Anti-Obesity Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-Obesity Drugs Sales Share by Manufacturers
Figure 2016 Anti-Obesity Drugs Sales Share by Manufacturers
Table United States Anti-Obesity Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Anti-Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Anti-Obesity Drugs Revenue Share by Manufacturers
Table 2016 United States Anti-Obesity Drugs Revenue Share by Manufacturers
Table United States Market Anti-Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Anti-Obesity Drugs Average Price of Key Manufacturers in 2015
Figure Anti-Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti-Obesity Drugs Market Share of Top 5 Manufacturers
Table United States Anti-Obesity Drugs Sales by States (2012-2017)
Table United States Anti-Obesity Drugs Sales Share by States (2012-2017)
Figure United States Anti-Obesity Drugs Sales Market Share by States in 2015
Table United States Anti-Obesity Drugs Revenue and Market Share by States (2012-2017)
Table United States Anti-Obesity Drugs Revenue Share by States (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by States (2012-2017)
Table United States Anti-Obesity Drugs Price by States (2012-2017)
Table United States Anti-Obesity Drugs Sales by Type (2012-2017)
Table United States Anti-Obesity Drugs Sales Share by Type (2012-2017)
Figure United States Anti-Obesity Drugs Sales Market Share by Type in 2015
Table United States Anti-Obesity Drugs Revenue and Market Share by Type (2012-2017)
Table United States Anti-Obesity Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Obesity Drugs by Type (2012-2017)
Table United States Anti-Obesity Drugs Price by Type (2012-2017)
Figure United States Anti-Obesity Drugs Sales Growth Rate by Type (2012-2017)
Table United States Anti-Obesity Drugs Sales by Application (2012-2017)
Table United States Anti-Obesity Drugs Sales Market Share by Application (2012-2017)
Figure United States Anti-Obesity Drugs Sales Market Share by Application in 2015
Table United States Anti-Obesity Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Obesity Drugs Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Anti-Obesity Drugs Sales Market Share (2012-2017)
Table F.Hoffmann-La Roche Basic Information List
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table F.Hoffmann-La Roche Anti-Obesity Drugs Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Anti-Obesity Drugs Sales Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table AstraZeneca Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Eisai Basic Information List
Table Eisai Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eisai Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Norgine Basic Information List
Table Norgine Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Norgine Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Anti-Obesity Drugs Sales Market Share (2012-2017)
Table Orexigen Therapeutics Basic Information List
Table Vivus Basic Information List
Table Alizyme Basic Information List
Table Rhythm Pharmaceuticals Basic Information List
Table Shionogi Basic Information List
Table Zafgan Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Drugs
Figure Manufacturing Process Analysis of Anti-Obesity Drugs
Figure Anti-Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti-Obesity Drugs
Table Distributors/Traders List
Figure United States Anti-Obesity Drugs Production and Growth Rate Forecast (2017-2022)
Figure United States Anti-Obesity Drugs Revenue and Growth Rate Forecast (2017-2022)
Table United States Anti-Obesity Drugs Production Forecast by Type (2017-2022)
Table United States Anti-Obesity Drugs Consumption Forecast by Application (2017-2022)
Table United States Anti-Obesity Drugs Sales Forecast by States (2017-2022)
Table United States Anti-Obesity Drugs Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *